Brief: ROVI H1 Revenue EUR 314.6 Million

Laboratorios Farmaceuticos Rovi

24/07/2025 06:38

Jul 24 (Reuters) - ROVI H1 free cash flow EUR 7.5 million.

H1 net income EUR 39.7 million

H1 EBITDA EUR 65.6 million

H1 EBIT EUR 50.9 million